Beacon Investment Advisory Services, Inc. Biogen Inc. Transaction History
Beacon Investment Advisory Services, Inc.
- $2.25 Billion
- Q2 2025
A detailed history of Beacon Investment Advisory Services, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 12,930 shares of BIIB stock, worth $1.67 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,930
Previous 16,080
19.59%
Holding current value
$1.67 Million
Previous $2.2 Million
26.23%
% of portfolio
0.07%
Previous 0.1%
Shares
32 transactions
Others Institutions Holding BIIB
# of Institutions
1,016Shares Held
131MCall Options Held
2.87MPut Options Held
2.57M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.23 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.04 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.87 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$963 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$619 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...